Development of immunocompetent full thickness skin tissue constructs to model skin fibrosis for high-throughput drug screening.

Biofabrication

National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, United States of America.

Published: December 2024

The lack of the immune component in most of the engineered skin models remains a challenge to study the interplay between different immune and non-immune cell types of the skin. Immunocompetent humanskin models offer potential advantages in recapitulatinglike behavior which can serve to accelerate translational research and therapeutics development for skin diseases. Here we describe a three-dimensional human full-thickness skin (FTS) equivalent incorporating polarized M1 and M2 macrophages from human peripheral CD14monocytes. This macrophage-incorporated FTS model demonstrates discernible immune responses with physiologically relevant cytokine production and macrophage plasticity under homeostatic and lipopolysaccharide stimulation conditions. M2-incorporated FTS recapitulates skin fibrosis phenotypes with transforming growth factor-1 treatment as reflected by significant collagen deposition and myofibroblast expression, demonstrating a M2 potentiation effect. In conclusion, we successfully biofabricated an immunocompetent FTS with functional macrophages in a high-throughput (HT) amenable format. This model is the first step towards a HT-assay platform to develop new therapeutics for skin diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11638742PMC
http://dx.doi.org/10.1088/1758-5090/ad998cDOI Listing

Publication Analysis

Top Keywords

skin
8
skin fibrosis
8
skin diseases
8
development immunocompetent
4
immunocompetent full
4
full thickness
4
thickness skin
4
skin tissue
4
tissue constructs
4
constructs model
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!